Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Functional Roles of NOD1 in Odontoblasts on Dental Pulp Innate Immunity.

Hosokawa Y, Hirao K, Yumoto H, Washio A, Nakanishi T, Takegawa D, Kitamura C, Matsuo T.

Biomed Res Int. 2016;2016:9325436.

2.

For Whom the Bell Tolls (and Nods): Spit-acular Saliva.

Shaw DK, Kotsyfakis M, Pedra JH.

Curr Trop Med Rep. 2016 Jun;3(2):40-50.

PMID:
27547699
3.

The Dual NOD1/NOD2 Agonism of Muropeptides Containing a Meso-Diaminopimelic Acid Residue.

Dagil YA, Arbatsky NP, Alkhazova BI, L'vov VL, Mazurov DV, Pashenkov MV.

PLoS One. 2016 Aug 11;11(8):e0160784. doi: 10.1371/journal.pone.0160784.

4.

Nod1 Limits Colitis-Associated Tumorigenesis by Regulating IFN-γ Production.

Zhan Y, Seregin SS, Chen J, Chen GY.

J Immunol. 2016 Jun 15;196(12):5121-9. doi: 10.4049/jimmunol.1501822.

PMID:
27183588
5.

Association of NOD1, CXCL16, STAT6 and TLR4 gene polymorphisms with Malaysian patients with Crohn's disease.

Chua KH, Ng JG, Ng CC, Hilmi I, Goh KL, Kee BP.

PeerJ. 2016 Mar 31;4:e1843. doi: 10.7717/peerj.1843.

6.

Ubiquitin signaling in immune responses.

Hu H, Sun SC.

Cell Res. 2016 Apr;26(4):457-83. doi: 10.1038/cr.2016.40. Review.

7.

Activation of Nod1 Signaling Induces Fetal Growth Restriction and Death through Fetal and Maternal Vasculopathy.

Inoue H, Nishio H, Takada H, Sakai Y, Nanishi E, Ochiai M, Onimaru M, Chen SJ, Matsui T, Hara T.

J Immunol. 2016 Mar 15;196(6):2779-87. doi: 10.4049/jimmunol.1500295.

8.

Comparative Analysis of the Flax Immune Receptors L6 and L7 Suggests an Equilibrium-Based Switch Activation Model.

Bernoux M, Burdett H, Williams SJ, Zhang X, Chen C, Newell K, Lawrence GJ, Kobe B, Ellis JG, Anderson PA, Dodds PN.

Plant Cell. 2016 Jan;28(1):146-59. doi: 10.1105/tpc.15.00303.

PMID:
26744216
9.

Prediction of tissue-specific effects of gene knockout on apoptosis in different anatomical structures of human brain.

Petrovskiy ED, Saik OV, Tiys ES, Lavrik IN, Kolchanov NA, Ivanisenko VA.

BMC Genomics. 2015;16 Suppl 13:S3. doi: 10.1186/1471-2164-16-S13-S3.

10.

Inflammatory Signaling by NOD-RIPK2 Is Inhibited by Clinically Relevant Type II Kinase Inhibitors.

Canning P, Ruan Q, Schwerd T, Hrdinka M, Maki JL, Saleh D, Suebsuwong C, Ray S, Brennan PE, Cuny GD, Uhlig HH, Gyrd-Hansen M, Degterev A, Bullock AN.

Chem Biol. 2015 Sep 17;22(9):1174-84. doi: 10.1016/j.chembiol.2015.07.017.

11.

Inhibiting the inflammasome: one domain at a time.

Dorfleutner A, Chu L, Stehlik C.

Immunol Rev. 2015 May;265(1):205-16. doi: 10.1111/imr.12290. Review.

12.

Regulation of inflammasome activation.

Man SM, Kanneganti TD.

Immunol Rev. 2015 May;265(1):6-21. doi: 10.1111/imr.12296. Review.

13.

The role of innate immunity receptors in the pathogenesis of inflammatory bowel disease.

Elia PP, Tolentino YF, Bernardazzi C, de Souza HS.

Mediators Inflamm. 2015;2015:936193. doi: 10.1155/2015/936193. Review.

14.

Comparative genomic analysis of buffalo (Bubalus bubalis) NOD1 and NOD2 receptors and their functional role in in-vitro cellular immune response.

Brahma B, Kumar S, De BC, Mishra P, Patra MC, Gaur D, Chopra M, Gautam D, Mahanty S, Malik H, Malakar D, Datta TK, De S.

PLoS One. 2015 Mar 18;10(3):e0119178. doi: 10.1371/journal.pone.0119178.

15.

Current knowledge and future directions of TLR and NOD signaling in sepsis.

Foley NM, Wang J, Redmond HP, Wang JH.

Mil Med Res. 2015 Jan 7;2:1. doi: 10.1186/s40779-014-0029-7.

16.

Various forms of tissue damage and danger signals following hematopoietic stem-cell transplantation.

Ramadan A, Paczesny S.

Front Immunol. 2015 Jan 28;6:14. doi: 10.3389/fimmu.2015.00014. Review.

17.

NOD1 and NOD2: signaling, host defense, and inflammatory disease.

Caruso R, Warner N, Inohara N, Núñez G.

Immunity. 2014 Dec 18;41(6):898-908. doi: 10.1016/j.immuni.2014.12.010. Review.

18.

Thymidine phosphorylase activates NFκB and stimulates the expression of angiogenic and metastatic factors in human cancer cells.

Tabata S, Ikeda R, Yamamoto M, Shimaoka S, Mukaida N, Takeda Y, Yamada K, Soga T, Furukawa T, Akiyama S.

Oncotarget. 2014 Nov 15;5(21):10473-85.

19.

NOD2 contributes to Porphyromonas gingivalis-induced bone resorption.

Prates TP, Taira TM, Holanda MC, Bignardi LA, Salvador SL, Zamboni DS, Cunha FQ, Fukada SY.

J Dent Res. 2014 Nov;93(11):1155-62. doi: 10.1177/0022034514551770.

20.

Synergistic effects of NOD1 or NOD2 and TLR4 activation on mouse sickness behavior in relation to immune and brain activity markers.

Farzi A, Reichmann F, Meinitzer A, Mayerhofer R, Jain P, Hassan AM, Fröhlich EE, Wagner K, Painsipp E, Rinner B, Holzer P.

Brain Behav Immun. 2015 Feb;44:106-20. doi: 10.1016/j.bbi.2014.08.011.

Items per page

Supplemental Content

Support Center